Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
Sonoma pharmaceuticals第四季度每股收益爲$(0.07)，同比從$(0.31)上升，銷售額爲$3.44M，低於$3.98M的預期。
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $3.44 million which missed the analyst consensus estimate of $3.98 million by 13.59 percent. This is a 14.10 percent increase over sales of $3.01 million the same period last year.
sonoma pharmaceuticals（納斯達克：SNOA）報告每股虧損$（0.07），同比去年同期虧損$（0.31）的77.42％。公司報告季度銷售額爲344萬美元，較分析師平均估計的398萬美元低13.59％。這是公司去年同期301萬美元銷售額的增長14.10％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。